Vladimir Tolmachev Selected Research

Vladimir Tolmachev Research Topics

Disease

168	Neoplasms (Cancer) 05/2022 - 01/2002
26	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 04/2011
25	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2004
16	Neoplasm Metastasis (Metastasis) 05/2022 - 11/2004
14	Carcinoma (Carcinomatosis) 05/2020 - 11/2004
6	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 06/2005
6	Squamous Cell Carcinoma of Head and Neck 12/2019 - 11/2004
5	Glioma (Gliomas) 01/2018 - 05/2003
5	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 08/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 10/2005
5	Neoplasm Micrometastasis 09/2009 - 02/2002
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 02/2015
2	Lymphoma (Lymphomas) 06/2022 - 05/2020
2	Disease Progression 01/2021 - 06/2019
2	Adenocarcinoma 02/2020 - 05/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2016 - 01/2011
1	Osteosarcoma (Osteogenic Sarcoma) 05/2022
1	Triple Negative Breast Neoplasms 10/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2020
1	Hypoxia (Hypoxemia) 12/2019

Drug/Important Bio-Agent (IBA)

68	Radioisotopes (Radionuclides)IBA 05/2022 - 02/2002
35	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2004
25	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2004
25	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2020 - 02/2007
18	Monoclonal AntibodiesIBA 01/2022 - 11/2004
17	Trastuzumab (Herceptin)FDA Link 01/2022 - 06/2005
16	Bombesin Receptors (Bombesin Receptor)IBA 11/2021 - 01/2013
16	Chelating AgentsIBA 03/2020 - 11/2006
13	human ERBB2 proteinIBA 01/2022 - 06/2005
13	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 11/2021 - 05/2011
12	AntigensIBA 07/2020 - 10/2005
11	Epidermal Growth Factor (EGF)IBA 01/2021 - 05/2003
10	Pharmaceutical PreparationsIBA 02/2022 - 10/2007
10	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 03/2012
8	Designed Ankyrin Repeat ProteinsIBA 05/2022 - 01/2018
8	AntibodiesIBA 06/2020 - 08/2003
7	BombesinIBA 01/2020 - 01/2013
7	Pentetic Acid (DTPA)FDA LinkGeneric 12/2019 - 08/2003
7	Cys-ZHER2-342 affibodyIBA 01/2018 - 02/2007
6	Epithelial Cell Adhesion MoleculeIBA 05/2022 - 02/2020
6	AlbuminsIBA 02/2022 - 01/2018
6	Peptides (Polypeptides)IBA 10/2020 - 01/2002
6	ABY-025IBA 03/2020 - 04/2010
6	AndrogensIBA 07/2014 - 04/2011
5	Indium-111IBA 07/2021 - 04/2007
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2014
5	LigandsIBA 06/2020 - 04/2006
4	Immunoconjugates (Immunoconjugate)IBA 05/2022 - 11/2006
3	seribantumabIBA 09/2021 - 01/2018
3	Carbonic Anhydrase IXIBA 12/2019 - 11/2016
3	Hormones (Hormone)IBA 01/2019 - 04/2011
3	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2010
3	Peptide Nucleic AcidsIBA 01/2018 - 01/2016
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017 - 03/2009
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2016 - 01/2007
3	Cysteine (L-Cysteine)FDA Link 04/2015 - 03/2007
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 02/2016
2	EpitopesIBA 11/2021 - 05/2012
2	Aligeron (AS 2)IBA 01/2021 - 06/2010
2	68Ga-ABY-025IBA 03/2020 - 01/2016
2	EnzymesIBA 01/2020 - 11/2016
2	G250 monoclonal antibodyIBA 12/2019 - 02/2015
2	CobaltIBA 11/2019 - 01/2017
2	Immunoglobulin FragmentsIBA 10/2019 - 02/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2016
2	pertuzumabIBA 01/2018 - 01/2007
2	Technetium (Technetium 99m)IBA 01/2018 - 03/2006
2	CD44v6 antigenIBA 02/2016 - 01/2010
2	Oncogene Proteins (Oncogene Protein)IBA 10/2015 - 06/2006
2	IndiumIBA 06/2014 - 11/2007
2	IodineIBA 06/2014 - 03/2006
2	IsotopesIBA 07/2013 - 11/2004
2	RadiopharmaceuticalsIBA 03/2011 - 03/2007
2	DABIIBA 01/2010 - 11/2004
2	dodecaborateIBA 01/2010 - 11/2004
2	benzyl-DTPAIBA 09/2007 - 08/2003
2	N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA 03/2007 - 11/2006
2	Benzoates (Benzoate)IBA 07/2006 - 11/2004
1	Alkaline PhosphataseIBA 05/2022
1	OsteopontinIBA 05/2022
1	ExotoxinsIBA 05/2022
1	Gallium-66IBA 11/2021
1	glycylhistidineIBA 01/2021
1	Copper-64IBA 12/2020
1	Cobalt-55IBA 12/2020
1	Human Serum Albumin FDA LinkGeneric 10/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	phosphoramidonIBA 12/2019
1	pimonidazoleIBA 12/2019
1	GlutamatesIBA 08/2019

Therapy/Procedure

86	Therapeutics 05/2022 - 02/2002
7	Radioimmunotherapy 08/2015 - 10/2005
7	Gamma Cameras (Gamma Camera) 11/2014 - 04/2006
3	Radiotherapy 12/2019 - 01/2007
2	Investigational Therapies (Experimental Therapy) 12/2020 - 01/2007
2	Precision Medicine 07/2019 - 10/2015
2	Immunotherapy 01/2018 - 01/2014
2	Intravenous Injections 05/2014 - 05/2012
1	Cyclotrons 11/2021